chr8-144513139-C-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004260.4(RECQL4):c.2464-1G>C variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000795 in 1,558,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004260.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2464-1G>C | splice_acceptor_variant, intron_variant | Intron 14 of 20 | 1 | NM_004260.4 | ENSP00000482313.2 | |||
RECQL4 | ENST00000621189.4 | c.1393-1G>C | splice_acceptor_variant, intron_variant | Intron 13 of 19 | 1 | ENSP00000483145.1 | ||||
RECQL4 | ENST00000534626.6 | c.634-1G>C | splice_acceptor_variant, intron_variant | Intron 5 of 7 | 5 | ENSP00000477457.1 | ||||
ENSG00000265393 | ENST00000580385.1 | n.271+302C>G | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000120 AC: 18AN: 149460Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000105 AC: 21AN: 200494Hom.: 0 AF XY: 0.0000922 AC XY: 10AN XY: 108492
GnomAD4 exome AF: 0.0000752 AC: 106AN: 1409346Hom.: 0 Cov.: 66 AF XY: 0.0000749 AC XY: 52AN XY: 694262
GnomAD4 genome AF: 0.000120 AC: 18AN: 149460Hom.: 0 Cov.: 34 AF XY: 0.000124 AC XY: 9AN XY: 72842
ClinVar
Submissions by phenotype
not provided Pathogenic:3
RECQL4: PVS1 -
- -
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31589614, 32775946, 18716613, 30687805, 34869606, 35833951, 31794323, 33077847, 37331604, 38413718, 29625052, 36451132, 12734318, 31887429, 36744932) -
Rothmund-Thomson syndrome type 2 Pathogenic:2
The homozygous c.2464-1G>C variant identified in the RECQL4 gene is a canonical splice variant within intron 14/20, and is predicted to lead to aberrant splicing by in silico algorithm SpliceAI (delta score: 0.98 for an acceptor loss -1bp). This variant is found with low frequency in population databases (gnomADv2.1.1, gnomADv3.2.1, BRAVO-TOPMed, All of Us) with highest allele frequency in BRAVO-TOPMed (29 heterozygotes, 0 homozygotes, allele frequency: 1.10e-4), suggesting it is not a common benign variant in the populations represented in those databases. The c.2464-1G>C variant in RECQL4 is reported in ClinVar as Pathogenic (VarID:94889; 2 stars, 3 submissions, no conflicts), and has been previously reported in homozygous state in two siblings with a clinical diagnosis of Rothmund-Thomson syndrome [PMID:12734318] and in compound heterozygosity with a different canonical splice variant in an unrelated patient with a clinical diagnosis of Rothmund-Thomson syndrome [PMID:18716613]. Given its expected deleterious nature, low frequency in population databases, and presence in several affected individuals in the literature in both homozygous state and in compound heterozygosity, the homozygous c.2464-1G>C variant identified in the RECQL4 gene is reported as Pathogenic. -
The RECQL4 c.2464-1G>C intronic change results in a G to C substitution at the -1 position of intron 14 of the RECQL4 gene and is predicted to disrupt the acceptor splice site. This variant has been identified in the homozygous state in siblings with clinical features of Rothmund-Thomson syndrome (PMID: 12734318), and in the compound heterozygous state in an unrelated individual with clinical features of Rothmund-Thomson syndrome (PMID: 18716613). It has also been identified as heterozygous in at least one individual with leiomyosarcoma (PMID: 29625052). This variant has a maximum founder subpopulation frequency of 0.31% and a maximum non-founder subpopulation frequency of 0.0011% in gnomAD v2.1.1. In summary, this variant meets criteria to be classified as pathogenic. -
Baller-Gerold syndrome;C1849453:Rapadilino syndrome;C5203410:Rothmund-Thomson syndrome type 2 Pathogenic:1
- -
Baller-Gerold syndrome Pathogenic:1
This sequence change affects an acceptor splice site in intron 14 of the RECQL4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs398124117, gnomAD 0.3%). Disruption of this splice site has been observed in individual(s) with clinical features of Rothmund-Thomson syndrome (PMID: 12734318, 18716613, 29625052). It has also been observed to segregate with disease in related individuals. This variant is also known as g.4615G>C. ClinVar contains an entry for this variant (Variation ID: 94889). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at